Magnus Baumhakel

Summary

Country: Germany

Publications

  1. ncbi Hotline sessions presented at the American College of Cardiology Congress 2009
    Lars S Maier
    Department of Cardiology and Pneumology, Heart Center, Georg August University Gottingen, Germany
    Clin Res Cardiol 98:345-52. 2009
  2. ncbi Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study
    Magnus Baumhakel
    Department of Cardiology, University Hospital of the Saarland, Kirrbergerstr 1, 66421 Homburg Saar, Germany
    Eur J Heart Fail 11:299-303. 2009
  3. ncbi [Erectile dysfunction: indicator of end-organ damage in cardiovascular patients]
    Magnus Baumhakel
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, 66421, Homburg Saar
    Med Klin (Munich) 104:309-13. 2009
  4. ncbi Telmisartan prevents cardiovascular events in a broad group of at-risk patients
    Magnus Baumhakel
    University Hospital of the Saarland, Department of Cardiology, Homburg Saar, Germany
    Expert Opin Pharmacother 10:3113-7. 2009
  5. ncbi Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice
    Magnus Baumhakel
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, D 66421 Homburg Saar, Germany
    Atherosclerosis 212:55-62. 2010
  6. ncbi Recent achievements in the management of Raynaud's phenomenon
    Magnus Baumhakel
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Vasc Health Risk Manag 6:207-14. 2010
  7. ncbi [Novel anticoagulants for stroke prevention in atrial fibrillation]
    M Baumhakel
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes
    Dtsch Med Wochenschr 135:2304-8. 2010
  8. ncbi Cardiovascular risk, drugs and erectile function--a systematic analysis
    M Baumhakel
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Int J Clin Pract 65:289-98. 2011
  9. ncbi Cardiovascular outcomes with angiotensin II receptor blockers: clinical implications of recent trials
    Magnus Baumhakel
    Department of Cardiology, University Hospital of Saarland, Homburg Saar, Germany
    Vasc Health Risk Manag 7:391-7. 2011
  10. ncbi Improvement of endothelial function of the corpus cavernosum in apolipoprotein E knockout mice treated with irbesartan
    Magnus Baumhakel
    Klinik fur Innere Medizin III, Kardiologie, Angiologie, und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    J Pharmacol Exp Ther 327:692-8. 2008

Detail Information

Publications27

  1. ncbi Hotline sessions presented at the American College of Cardiology Congress 2009
    Lars S Maier
    Department of Cardiology and Pneumology, Heart Center, Georg August University Gottingen, Germany
    Clin Res Cardiol 98:345-52. 2009
    ..The summaries presented in the manuscript were generated from the oral presentations and provide the readers with the comprehensive information on the results of the latest clinical trials in cardiovascular medicine...
  2. ncbi Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study
    Magnus Baumhakel
    Department of Cardiology, University Hospital of the Saarland, Kirrbergerstr 1, 66421 Homburg Saar, Germany
    Eur J Heart Fail 11:299-303. 2009
    ..We aimed to determine the interactions of gender with medical treatment of CHF...
  3. ncbi [Erectile dysfunction: indicator of end-organ damage in cardiovascular patients]
    Magnus Baumhakel
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, 66421, Homburg Saar
    Med Klin (Munich) 104:309-13. 2009
    ..Furthermore, different trials suggest erectile function as a strong predictor of cardiovascular events like myocardial infarction or stroke...
  4. ncbi Telmisartan prevents cardiovascular events in a broad group of at-risk patients
    Magnus Baumhakel
    University Hospital of the Saarland, Department of Cardiology, Homburg Saar, Germany
    Expert Opin Pharmacother 10:3113-7. 2009
    ..In these patients who are intolerant to ACE-Is or who do not achieve blood pressure control, the ARB with the best evidence for secondary prevention is telmisartan according to the results of the ONTARGET trial...
  5. ncbi Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice
    Magnus Baumhakel
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, D 66421 Homburg Saar, Germany
    Atherosclerosis 212:55-62. 2010
    ..To determine the effect of heart rate reduction with ivabradine on atherosclerotic lesions and erectile dysfunction...
  6. ncbi Recent achievements in the management of Raynaud's phenomenon
    Magnus Baumhakel
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Vasc Health Risk Manag 6:207-14. 2010
    ..This review addresses current evidence for medical treatment of primary and secondary Raynaud's phenomenon with regard to pathophysiological mechanisms as well as future perspectives...
  7. ncbi [Novel anticoagulants for stroke prevention in atrial fibrillation]
    M Baumhakel
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes
    Dtsch Med Wochenschr 135:2304-8. 2010
    ..This review addresses the new anticoagulants Apixaban, Rivaroxban and Dabigatranetexilat with the design and as available the results of the corresponding phase-III-trials in atrial fibrillation (ARISTOTLE, ROCKET-AF, RE-LY)...
  8. ncbi Cardiovascular risk, drugs and erectile function--a systematic analysis
    M Baumhakel
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Int J Clin Pract 65:289-98. 2011
    ..Drugs used for evidence-based treatment of cardiovascular diseases have been reported to decrease erectile function, but possible mechanisms are poorly characterised...
  9. ncbi Cardiovascular outcomes with angiotensin II receptor blockers: clinical implications of recent trials
    Magnus Baumhakel
    Department of Cardiology, University Hospital of Saarland, Homburg Saar, Germany
    Vasc Health Risk Manag 7:391-7. 2011
    ..This article reviews the implications of these trials for the optimal management of cardiovascular risk...
  10. ncbi Improvement of endothelial function of the corpus cavernosum in apolipoprotein E knockout mice treated with irbesartan
    Magnus Baumhakel
    Klinik fur Innere Medizin III, Kardiologie, Angiologie, und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    J Pharmacol Exp Ther 327:692-8. 2008
    ..This result emphasizes the beneficial effect of inhibition of the renin-angiotensin system even in terms of erectile function...
  11. ncbi Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome
    M Baumhakel
    Kardiologie, Angiologie und Internistische Intensivmedizin, Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, Homburg, Germany
    Int J Impot Res 20:493-500. 2008
    ..These results suggest a beneficial role of angiotensin receptor antagonists in the treatment of metabolic syndrome, and ED...
  12. ncbi Circulating endothelial progenitor cells correlate with erectile function in patients with coronary heart disease
    Magnus Baumhakel
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, D 66421 Homburg Saar, Germany
    Eur Heart J 27:2184-8. 2006
    ..The aim of the study was to determine the influence of endothelial progenitor cells (EPC) on erectile dysfunction (ED). EPC play a major role in repair mechanisms of the endothelial monolayer, but the role of EPC in ED is unclear...
  13. ncbi Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice
    Magnus Baumhakel
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, D 66421 Homburg Saar, Germany
    J Pharmacol Exp Ther 325:818-23. 2008
    ..These effects may be related to a reduction of ROS production, which is independent of heart rate reduction, because metoprolol did not increase endothelial function...
  14. ncbi Erectile dysfunction correlates with left ventricular function and precedes cardiovascular events in cardiovascular high-risk patients
    M Baumhakel
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, D 66421 Homburg Saar, Germany
    Int J Clin Pract 61:361-6. 2007
    ..Hence, ED is suggested to be an early symptom of generalised cardiovascular disease and events. Thus, cardiovascular evaluation is recommended in patients with ED providing the opportunity of optimised preventional treatment...
  15. ncbi [Cardiovascular pharmacotherapy in the aged]
    M Baumhakel
    Innere Medizin III, Medizinische Klinik und Poliklinik, Universitatskliniken des Saarlandes, Homburg
    Internist (Berl) 44:943-50. 2003
    ..This review addresses both, the treatment of cardiovascular diseases in the elderly and the pharmacological characteristics of frequently used drugs...
  16. ncbi Soccer world championship: a challenge for the cardiologist
    Magnus Baumhakel
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, D 66421 Homburg Saar, Germany
    Eur Heart J 28:150-3. 2007
    ..Thus, the increased risk of cardiovascular events in players and spectators were addressed in this review with respect to various soccer matches and tournaments, such as the FIFA World Cup...
  17. ncbi Use of tadalafil in a patient with a secondary Raynaud's phenomenon not responding to sildenafil
    Magnus Baumhaekel
    Department of Cardiology and Angiology, University Hospital of the Saarland, Kirrbergerstr, 66421 Homburg Saar, Germany
    Microvasc Res 69:178-9. 2005
    ..Therefore, therapy of Raynaud's phenomenon with the new PDE-V-inhibitor tadalafil seems to be an effective treatment option in patients not responding to sildenafil...
  18. ncbi Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice
    Florian Custodis
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, 66424 Homburg Saar, Germany
    Circulation 117:2377-87. 2008
    ..We hypothesized that selective heart rate reduction may influence endothelial function and atherogenesis and tested the effects of the I(f) current inhibitor ivabradine in apolipoprotein E-deficient mice...
  19. ncbi From evidence to rationale: cardiovascular protection by angiotensin II receptor blockers compared with angiotensin-converting enzyme inhibitors
    Michael Bohm
    Department of Internal Medicine III, Cardiology, Angiology and Intensive Care Medicine, Saarland University Hospital, Homburg Saar, Germany
    Cardiology 117:163-73. 2010
    ....
  20. ncbi RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection
    Christian Werner
    Klinik für Innere Medizin III Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Clin Res Cardiol 97:418-31. 2008
    ....
  21. ncbi Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtoler
    Michael Bohm
    Department of Cardiology, University of the Saarland, Saarbrucken, Germany
    Circulation 121:1439-46. 2010
    ....
  22. ncbi Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telm
    Michael Bohm
    Klinik für Innere Medizin III des Universitätsklinikum des Saarlandes, Saarland, Homburg, Germany
    Am Heart J 154:94-101. 2007
    ..The effects of treatment with telmisartan and ramipril, alone or in combination, including a telmisartan versus placebo arm will be determined prospectively during a follow-up of 4 years...
  23. ncbi Vascular pathophysiology in response to increased heart rate
    Florian Custodis
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    J Am Coll Cardiol 56:1973-83. 2010
    ....
  24. ncbi Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments
    Stephan H Schirmer
    Klinik für Innere Medizin III Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    J Am Coll Cardiol 56:2067-76. 2010
    ..This review focuses on current advances in the development of directly acting oral anticoagulant drugs and their potential to replace the VKA class of drugs in patients with AF...
  25. ncbi Inadequate Reporting of Concomitant Drug Treatment in Cardiovascular Interventional Head-to-Head Trials
    Felix Mahfoud
    University Hospital of the Saarland, Homburg, Germany
    Clin Cardiol 35:255-6. 2012
    ..Although medical prevention has been clearly shown to be beneficial in coronary artery disease, it has been suggested that patients were significantly undertreated with evidence-based medications for cardiovascular protection...